Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 5 55-5, 2004, Pages

  McCully, James D ^a,b   Wakiyama, Hidetaka ^a   Hsieh, Yng Ju ^a   Jones, Mara ^a   Levitsky, Sidney ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Caspase; Myocardium

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE INHIBITOR; FAS ACTIVATED DEATH DOMAIN PROTEIN; FAS LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; INHIBITION KINETICS; NECROSIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION; REPERFUSION INJURY; STAINING; SYSTOLE; TIME;

ANIMALS; APOPTOSIS; CASPASES; CYSTEINE PROTEINASE INHIBITORS; HEMODYNAMIC PROCESSES; IN SITU NICK-END LABELING; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NECROSIS; OLIGOPEPTIDES; RABBITS; RECOVERY OF FUNCTION;

EID: 1942501599     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00935.2003     Document Type: Article

References (52)

1. Andrews NC and Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499, 1991.
2. Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, and Kajstura J. Apoptosis and myocardial infarction. Basic Res Cardiol 93, Suppl 3: 8-12, 1998.
3. Baxter GF and Yellon DM. Current trends and controversies in ischemia-reperfusion research. Basic Res Cardiol 98: 133-136, 2003.
4. Bennett MR. Apoptosis in the cardiovascular system. Heart 87: 480-487, 2002.
5. Bialik S, Cryns VL, Drincic A, Miyata S, Wollowick AL, Srinivasan A, and Kitsis RN. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res 85: 403-414, 1999.
6. Birnbaum Y, Hale SL, and Kloner RA. Differences in reperfusion length following 30 min of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. J Mol Cell Cardiol 29: 657-666, 1997.
7. Buja LM and Entman ML. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 98: 1355-1357, 1998.
8. Cai J, Yang J, and Jones DP. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta 1366: 139-149, 1998.
9. Connelly C, Vogel WM, Hernandez YM, and Apstein CS. Movement of necrotic wave front after coronary artery occlusion in rabbit. Am J Physiol Heart Circ Physiol 243: H682-H690, 1982.
10. Elsasser A, Suzuki K, and Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 32: 711-724, 2000.
11. Fauvel H, Marchetti P, Chopin C, Formstecher P, and Neviere R. Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis. Am J Physiol Heart Circ Physiol 280: H1608-H1614, 2001.
12. Feinberg H, Levitsky S, and Lee SL. The quiescent heart: excitability, compliance, and vascular resistance. Am J Physiol Heart Circ Physiol 251: H1085-H1089, 1986.
13. Freude B, Masters TN, Robicsek F, Fokin A, Kostin S, Zimmermann R, Ullmann C, Lorenz-Meyer S, and Schaper J. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 32: 197-208, 2000.
14. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, and Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.
15. Green DR and Reed JC. Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
16. Haunstetter A and Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82: 1111-1129, 1998.
17. Holly TA, Drincic A, Byun Y, Nakamura S, Harris K, Klocke FJ, and Cryns VL. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 31: 1709-1715, 1999.
18. Hsieh Y, Levitsky S, and McCully JD. Cardioplegia modulates apoptosis through down-regulation of pro-apoptotic transcription factor STAT1 tyrosine phosphorylation and the bcl-2-sensitive apoptosis pathway (Abstract). Circulation 108: IV-509, 2003.
19. Huang JQ, Radinovic S, Rezaiefar P, and Black SC. In vivo myocardial infarct size reduction by a caspase inhibitor administered after the onset of ischemia. Eur J Pharmacol 402: 139-142, 2000.
20. James TN. The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: significance for understanding its pathogenesis, clinical course, diagnosis and prognosis. Coron Artery Dis 9: 291-307, 1998.
21. Klein HH, Puschman S, Schaper J, and Schaper W. The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. J Clin Pathol 19: 479-481, 1981.
22. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
23. Liu H, McPherson BC, and Yao Z. Preconditioning attenuates apoptosis and necrosis: role of protein kinase C-ε and -δ isoforms. Am J Physiol Heart Circ Physiol 281: H404-H410, 2001.
24. Lowry OH, Rosenberg NJ, Farr AL, and Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
25. Maulik N, Yoshida T, Engelman RM, Deaton D, Flack JE 3rd, Rousou JA, and Das DK. Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem 186: 139-145, 1998.
26. McConkey DJ. Biochemical determinants of apoptosis and necrosis. Toxicol Lett 99: 157-168, 1998.
27. McCully JD, Lotz MM, Krukenkamp IB, and Levitsky S. A brief period of retrograde hyperthermic perfusion enhances myocardial protection from global ischemia: association with accumulation of Hsp 70 mRNA and protein. J Mol Cell Cardiol 28: 231-241, 1996.
28. McCully JD, Wakiyama H, Cowan DB, Federman M, and Levitsky S. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery. Ann Thorac Surg 74: 2138-2146, 2002.
29. Mocanu MM, Baxter GF, and Yellon DM. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol 130: 197-200, 2000.
30. Nagata S. Apoptosis by death factor. Cell 88: 355-365, 1997.
31. Nuess M, Crow MT, Chesley A, and Lakatta EG. Apoptosis in cardiac disease-what is it-how does it occur. Cardiovasc Drugs Ther 15: 507-523, 2001.
32. Ohno M, Takemura G, Ohno A, Miaso J, Hayahawa Y, Minatoguchi S, Fujiwara T, and Fujiwara H. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nicked-labeling. Circulation 98: 1422-1430, 1998.
33. Okamura T, Miura T, Takemura G, Fujiwara H, Iwamoto H, Kawamura S, Kimura M, Ikeda Y, Iwatate M, and Matsuzaki M. Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfusion rat heart. Cardiovasc Res 45: 642-650, 2000.
34. Qiu Y and Hearse DJ. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts. J Thorac Cardiovasc Surg 103: 960-968, 1992.
35. Sandhu R, Diaz RJ, and Wilson GJ. Comparison of ischemic preconditioning in blood perfusion and buffer perfused isolated heart model. Cardiovasc Res 27: 602-607, 1993.
36. Shaper J, Elsasser A, and Kostin S. The role of cell death in heart failure. Circ Res 85: 867-869, 1999.
37. Saraste A and Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45: 528-537, 2000.
38. Schotte P, Declercq W, Van Huffel S, Vandenabeele P, and Beyaert R. Non-specific effects of metyl ketone peptide inhibitors of caspases. FEBS Lett 442: 117-121, 1999.
39. Stadler B, Phillips J, Toyoda Y, Federman M, Levitsky S, and McCully JD. Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis: effects of stunning and ischemia-reperfusion. Ann Thorac Surg 72: 555-564, 2001.
40. Steller H. Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995.
41. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC, and Kroemer G. Two distinct pathways leading to nuclear apoptosis. J Exp Med 192: 571-579, 2000.
42. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, and Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184: 1331-1341, 1996.
43. Susin SA, Zamzami N, and Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1366: 151-165, 1998.
44. Suzuki K, Kostin S, Person V, Elsasser A, and Schaper J. Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes. J Mol Cell Cardiol 33: 983-994, 2001.
45. Toyoda Y, Friehs I, Parker RA, Levitsky S, and McCully JD. Differential role of sarcolemmal and mitochondrial ATP-sensitive potassium channels in adenosine enhanced ischemic preconditioning. Am J Physiol Heart Circ Physiol 279: H2694-H2703, 2000.
46. Toyoda Y, Gregorio VD, Parker RA, Levitsky S, and McCully JD. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning. Circulation 102: 111326-111331, 2000.
47. Vaux DL and Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 93: 2239-2244, 1996.
48. Wakiyama H, Cowan DB, Toyoda Y, Federman M, Levitsky S, and McCully J-D. Selective opening of mitochondrial ATP-sensitive potassium channels during surgically induced myocardial ischemia decreases necrosis and apoptosis. Eur J Cardiothorac Surg 21: 424-433, 2002.
49. Weisel RD. Models of myocardial stunning. J Card Surg 8, Suppl 2: 287-290, 1993.
50. Ytrehus K, Liu Y, Tsuchida A, Miura T, Liu GS, Yang XM, Herbert D, Cohen MV, Downey JM. Rat and rabbit heart infarction: effects of anesthesia, perfusion, risk zone, and method of infarct sizing. Am J Physiol Heart Circ Physiol 267: H2383-H2390, 1994.
51. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, and Vinten-Johansen J. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45: 651-660, 2000.
52. Zhao ZQ, Morris CD, Budde JM, Wang NP, Muraki S, Sun HY, and Guyton RA. Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res 59: 132-142, 2003.